These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 9510652)
1. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits. Yu HG; Chung H Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652 [TBL] [Abstract][Full Text] [Related]
2. Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy. Kuo HK; Wu PC; Yang PM; Chen YH; Wu YC; Hu DN J Ocul Pharmacol Ther; 2007 Feb; 23(1):14-20. PubMed ID: 17341145 [TBL] [Abstract][Full Text] [Related]
3. Effect of 2'-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. Lee JJ; Park JK; Kim YT; Kwon BM; Kang SG; Yoo YD; Yu YS; Chung H Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3117-24. PubMed ID: 12202537 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Yang CH; Huang TF; Liu KR; Chen MS; Hung PT Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869 [TBL] [Abstract][Full Text] [Related]
5. Effects of an intravitreal daunomycin implant on experimental proliferative vitreoretinopathy: simultaneous pharmacokinetic and pharmacodynamic evaluations. Rahimy MH; Peyman GA; Fernandes ML; el-Sayed SH; Luo Q; Borhani H J Ocul Pharmacol; 1994; 10(3):561-70. PubMed ID: 7836865 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of experimental proliferative vitreoretinopathy in rabbits]. Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164 [TBL] [Abstract][Full Text] [Related]
7. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy. Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404 [TBL] [Abstract][Full Text] [Related]
10. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy. Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931 [TBL] [Abstract][Full Text] [Related]
11. [The role of specific ROCK inhibitor in the prevention of experimental PVR in rabbits]. Zheng YP; Sun NX; Xiong QC; Quan YL; Wang F Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1112-8. PubMed ID: 16409766 [TBL] [Abstract][Full Text] [Related]
12. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E. Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model. Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176 [TBL] [Abstract][Full Text] [Related]
14. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR. Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176 [TBL] [Abstract][Full Text] [Related]
15. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin. Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400 [TBL] [Abstract][Full Text] [Related]
16. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294 [TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy. Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of growth inhibitory effect of Mitomycin-C on cultured human retinal pigment epithelial cells: apoptosis and cell cycle arrest. Kang SG; Chung H; Yoo YD; Lee JG; Choi YI; Yu YS Curr Eye Res; 2001 Mar; 22(3):174-81. PubMed ID: 11462153 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiproliferative effects of the somatostatin analogue somatuline in a rabbit model of traction retinal detachment. Baudouin C; Imbert F; Ettaiche M; Gastaud P Fundam Clin Pharmacol; 1995; 9(4):357-65. PubMed ID: 8566935 [TBL] [Abstract][Full Text] [Related]
20. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]